« Previous
Next »
Fertility and Sterility
Volume 78, Issue 5
, Pages 1068-1072
, November 2002
Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist
References
- Improved pregnancy outcome with gonadotropin releasing hormone agonist stimulation is due to the improvement in oocyte quantity rather than quality. J Assist Reprod Genet. 1992;9:338–344
- Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization. Fertil Steril. 1989;52:518–519
- Comparison of human menopausal gonadotropin, clomiphene citrate, and combined human menopausal gonadotropin-clomiphene citrate stimulation protocols for in vitro fertilization. Fertil Steril. 1986;46:1108–1112
- . Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. Fertil Steril. 1992;58:563–568
- . Clomiphene citrate and hMG (an alternative stimulation protocol for selected failed in vitro fertilization patients). J Assist Reprod Genet. 1995;12:8–12
- . A novel ovarian stimulation protocol for use with the assisted reproductive technologies. Fertil Steril. 1993;60:864–870
- . Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989;51:651–654
- . Timing of oocyte retrieval in cycles with a spontaneous luteinizing hormone surge in a large in vitro fertilization program. Fertil Steril. 1998;50:451–456
- . Combined impact of the number of pre-ovulatory oocytes and cryopreservation on IVF outcome. Hum Reprod. 1991;6:284–289
- . Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe, and convenient (results of a controlled, randomized, multicenter trial). Hum Reprod. 2000;15:1490–1498
- Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix) (a pilot study with minimal stimulation). Hum Reprod. 1999;14:683–688
PII: S0015-0282(02)03374-5
© 2002 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 78, Issue 5
, Pages 1068-1072
, November 2002

